About Prestwick Pharmaceuticals
Prestwick Pharmaceuticals is a company based in Washington (United States) founded in 2002 was acquired by Biovail in September 2008. Prestwick Pharmaceuticals has raised $103.79 million across 6 funding rounds from investors including Warburg Pincus, FirstMark and Atlas Venture. Prestwick Pharmaceuticals offers products and services including Antibodies, Assay Kits, ELISA Kits, and PCR Kits.
- Headquarter Washington, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$103.79 M (USD)
in 6 rounds
-
Latest Funding Round
$20 M (USD), Series C
Aug 27, 2007
-
Investors
Warburg Pincus
& 7 more
-
Employee Count
Not available
-
Acquired by
Biovail
(Sep 17, 2008)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Prestwick Pharmaceuticals
Prestwick Pharmaceuticals offers a comprehensive portfolio of products and services, including Antibodies, Assay Kits, ELISA Kits, and PCR Kits.
Used for detecting specific proteins in research and diagnostics.
Kits for testing biological samples in various assays.
Tools for enzyme-linked immunosorbent assays in disease detection.
Kits for polymerase chain reaction in DNA amplification.
Funding Insights of Prestwick Pharmaceuticals
Prestwick Pharmaceuticals has successfully raised a total of $103.79M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $20 million completed in August 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Prestwick Pharmaceuticals
Prestwick Pharmaceuticals has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Warburg Pincus, FirstMark and Atlas Venture.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in life science and biotechnology sectors
|
Locked | Locked | Locked | |
|
Early-stage venture capital is invested in tech startups across sectors.
|
Locked | Locked | Locked | |
|
Early-stage venture capital investments are focused on US companies.
|
Locked | Locked | Locked |
Investor details for Prestwick Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Prestwick Pharmaceuticals
Investment portfolio details for Prestwick Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Prestwick Pharmaceuticals
Detailed financials for Prestwick Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Prestwick Pharmaceuticals Comparisons
Peer comparison for Prestwick Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Prestwick Pharmaceuticals
Detailed competitors of Prestwick Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Prestwick Pharmaceuticals
Complete news archive for Prestwick Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prestwick Pharmaceuticals
Prestwick Pharmaceuticals was founded in 2002 and raised its 1st funding round 1 year after it was founded.
Prestwick Pharmaceuticals is headquartered in Washington, United States. It is registered at Washington, District Of Columbia, United States.
Prestwick Pharmaceuticals is a funded company, having raised a total of $103.79M across 6 funding rounds to date.
Prestwick Pharmaceuticals was founded in 2002 as a specialty pharmaceutical company focused on the development and commercialization of small molecule drugs targeting chronic central nervous system diseases. Operations included early-stage products such as Lisuride for Parkinsons disease and D-Serine for schizophrenia. An exclusive U.S. commercialization agreement for Xenazine in Huntingtons disease was established with Ovation Pharmaceuticals. The company was acquired by Biovail Corp. in September 2008.
Prestwick Pharmaceuticals offers Antibodies, Assay Kits, ELISA Kits, and PCR Kits.
Prestwick Pharmaceuticals has 8 investors. Key investors include Warburg Pincus, FirstMark, Atlas Venture, Biovail, and Scale Venture Partners.